Immunome (IMNM) News Today $9.63 -0.62 (-6.05%) As of 01:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMNM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Immunome, Inc. $IMNM Stock Position Lifted by Redmile Group LLCSeptember 4 at 7:28 AM | marketbeat.comImmunome to Present at the H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 3 at 8:00 AM | businesswire.comImmunome, Inc. (NASDAQ:IMNM) Given Average Recommendation of "Buy" by AnalystsSeptember 3 at 3:26 AM | marketbeat.comDriehaus Capital Management LLC Invests $4.11 Million in Immunome, Inc. $IMNMSeptember 2 at 5:57 AM | marketbeat.comNuveen LLC Takes Position in Immunome, Inc. $IMNMSeptember 1 at 3:32 AM | marketbeat.comVelan Capital Investment Management LP Buys New Shares in Immunome, Inc. $IMNMAugust 31, 2025 | marketbeat.comImmunome, Inc. $IMNM Shares Bought by Charles Schwab Investment Management Inc.August 31, 2025 | marketbeat.comAlphaQuest LLC Increases Holdings in Immunome, Inc. $IMNMAugust 30, 2025 | marketbeat.comVanguard Group Inc. Acquires 1,303,753 Shares of Immunome, Inc. $IMNMAugust 30, 2025 | marketbeat.comSwiss National Bank Boosts Stake in Immunome, Inc. $IMNMAugust 29, 2025 | marketbeat.comGuggenheim Reaffirms Buy Rating for Immunome (NASDAQ:IMNM)August 27, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Receives Buy Rating from GuggenheimAugust 26, 2025 | americanbankingnews.comT. Rowe Price Investment Management Inc. Has $50.84 Million Stake in Immunome, Inc. $IMNMAugust 25, 2025 | marketbeat.comEvercore ISI Initiates Coverage on Immunome (NASDAQ:IMNM)August 25, 2025 | americanbankingnews.comPiper Sandler Sticks to Their Buy Rating for Immunome (IMNM)August 24, 2025 | theglobeandmail.comGuggenheim Reaffirms Their Buy Rating on Immunome (IMNM)August 24, 2025 | theglobeandmail.comEvercore ISI Group Initiates Coverage of Immunome (IMNM) with Outperform RecommendationAugust 23, 2025 | msn.comFox Run Management L.L.C. Acquires New Holdings in Immunome, Inc. $IMNMAugust 23, 2025 | marketbeat.comWedbush Reaffirms Their Buy Rating on Immunome (IMNM)August 22, 2025 | theglobeandmail.comImmunome initiated with an Outperform at Evercore ISIAugust 22, 2025 | msn.comFreestone Capital Holdings LLC Buys New Shares in Immunome, Inc. $IMNMAugust 21, 2025 | marketbeat.comQ1 Earnings Forecast for Immunome Issued By Lifesci CapitalAugust 12, 2025 | marketbeat.comImmunome: SpringWorks Buyout Informs The Potential Upside HereAugust 11, 2025 | seekingalpha.comResearch Analysts Offer Predictions for Immunome Q3 EarningsAugust 11, 2025 | marketbeat.comWedbush Comments on Immunome's Q3 Earnings (NASDAQ:IMNM)August 11, 2025 | marketbeat.comJohnson Financial Group LLC Acquires 28,000 Shares of Immunome, Inc. (NASDAQ:IMNM)August 10, 2025 | marketbeat.comGrowth Investors: Industry Analysts Just Upgraded Their Immunome, Inc. (NASDAQ:IMNM) Revenue Forecasts By 73%August 9, 2025 | finance.yahoo.comPrimecap Management Co. CA Has $22.97 Million Stock Holdings in Immunome, Inc. (NASDAQ:IMNM)August 9, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Given New $22.00 Price Target at JPMorgan Chase & Co.August 8, 2025 | marketbeat.comWedbush Reiterates Outperform Rating for Immunome (NASDAQ:IMNM)August 8, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Given Average Rating of "Buy" by BrokeragesAugust 8, 2025 | marketbeat.comImmunome Advances Cancer Therapy Pipeline Amid Financial LossAugust 7, 2025 | tipranks.comImmunome (IMNM) Q2 Revenue Surges 382%August 6, 2025 | fool.comImmunome Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 6, 2025 | businesswire.comImmunome (IMNM) to Release Quarterly Earnings on MondayAugust 5, 2025 | marketbeat.comTD Asset Management Inc Acquires 183,460 Shares of Immunome, Inc. (NASDAQ:IMNM)August 3, 2025 | marketbeat.comImmunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | businesswire.comBank of New York Mellon Corp Boosts Stock Holdings in Immunome, Inc. (NASDAQ:IMNM)July 31, 2025 | marketbeat.comReadystate Asset Management LP Makes New Investment in Immunome, Inc. (NASDAQ:IMNM)July 23, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Shares Up 8.6% - What's Next?July 16, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Stock Price Down 5.5% - Here's WhyJuly 15, 2025 | marketbeat.com38,501 Shares in Immunome, Inc. (NASDAQ:IMNM) Acquired by Private Capital Advisors Inc.July 14, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Receives Consensus Recommendation of "Buy" from AnalystsJuly 14, 2025 | marketbeat.comImmunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 3, 2025 | businesswire.comImmunome (NASDAQ:IMNM) Shares Down 7.8% - Here's WhyJuly 1, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Trading Down 4% - Should You Sell?June 25, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Receives Average Rating of "Buy" from AnalystsJune 19, 2025 | marketbeat.comImmunome (NASDAQ:IMNM) Trading Down 6.7% - Should You Sell?June 13, 2025 | marketbeat.comBank of America Corp DE Sells 44,020 Shares of Immunome, Inc. (NASDAQ:IMNM)June 12, 2025 | marketbeat.comImmunome, Inc. (NASDAQ:IMNM) Shares Sold by Jane Street Group LLCJune 7, 2025 | marketbeat.com Get Immunome News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IMNM Media Mentions By Week IMNM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMNM News Sentiment▼1.270.69▲Average Medical News Sentiment IMNM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMNM Articles This Week▼104▲IMNM Articles Average Week Get the Latest News and Ratings for IMNM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Immunome and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TLX News Today SRRK News Today ARWR News Today VKTX News Today AMRX News Today XENE News Today KYMR News Today CRNX News Today RARE News Today MOR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMNM) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunome, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunome With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMNM Stock Alerts